Addison Advisors’s Moderna MRNA Stock Holding History

Addison Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.8K	Buy	+15	New	+$1.62K	﹤0.01%	574
2026 Q2	–	Sell	-12	Closed	-$610	–	886
2026 Q1	$610	Hold	12	–	–	﹤0.01%	917
2025 Q4	$354	Hold	12	–	–	﹤0.01%	871
2025 Q3	$310	Hold	12	–	–	﹤0.01%	864
2025 Q2	$332	Hold	12	–	–	﹤0.01%	852
2025 Q1	$341	Sell	12 -13	-52%	-$461	﹤0.01%	810
2024 Q4	$1.04K	Hold	25	–	–	﹤0.01%	785
2024 Q3	$1.67K	Sell	25 -25	-50%	-$2.3K	﹤0.01%	748
2024 Q2	$5.94K	Hold	50	–	–	﹤0.01%	614
2024 Q1	$5.33K	Hold	50	–	–	﹤0.01%	562
2023 Q4	$4.97K	Hold	50	–	–	﹤0.01%	573
2023 Q3	$5.16K	Hold	50	–	–	﹤0.01%	542
2023 Q2	$6.08K	Sell	50 -69	-58%	-$9.2K	﹤0.01%	520
2023 Q1	$18.3K	Sell	119 -3	-2%	-$495	0.01%	408
2022 Q4	$21.9K	Sell	122 -3	-2%	-$491	0.01%	368
2022 Q3	$15K	Hold	125	–	–	0.01%	391
2022 Q2	$18K	Buy	125 +6	+5%	+$858	0.01%	369
2022 Q1	$20K	Sell	119 -49	-29%	-$8.25K	0.01%	395
2021 Q4	$43K	Buy	+168	New	+$49.1K	0.03%	259

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

Addison Advisors's MRNA Position: Q3 2026 in Review

Addison Advisors opened a new position in Moderna (MRNA) in Q3 2026: 15 shares worth $2.8K. The stake represents ﹤0.01% of the portfolio and ranks #574 among its holdings. This is a return to the name: Addison Advisors previously reported a position in MRNA as recently as Q1 2026.

Addison Advisors first reported a position in MRNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $43K in Q4 2021. 573 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

Addison Advisors held 15 shares of Moderna worth $2.8K as of Q3 2026.
Moderna was a new Addison Advisors position in Q3 2026.
Moderna made up ﹤0.01% of Addison Advisors's portfolio in Q3 2026, its #574 holding.
Addison Advisors first reported a position in Moderna in Q4 2021 and has held it in 19 quarters since.
Addison Advisors's Moderna position peaked at $43K in Q4 2021.
573 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Addison Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.